Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Fiessinger

Showing results (1-10 of 304) with videos related to

Pageof 31
Sort By:
Bulletin De L'Academie Nationale De Medecine|May 1, 1997
[Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook]J N Fiessinger
Annales De Cardiologie Et D'Angeiologie|March 1, 1981
[Spasm and Raynaud's phenomenon]J N Fiessinger
Annals of Vascular Surgery|December 1, 1987
Thrombolytic therapy for venous thrombosisJ N Fiessinger
La Tunisie Medicale|May 3, 2001
[Diagnosis and treatment of deep venous thromboses: towards ambulatory management]J N Fiessinger
Revue Du Rhumatisme (English Ed.)|May 1, 1997
Thromboangiitis obliterans (Buerger's disease)J N Fiessinger
Drugs|December 9, 1998
[Diagnostic and therapeutic stragegies in peripheral obliterative arteriopathy: non-drug treatment]J N Fiessinger
La Revue De Medecine Interne|January 1, 1997
[Preventing and treating venous thrombosis in 1997]J N Fiessinger
Bulletin De L'Academie Nationale De Medecine|April 27, 2002
[Treatment of deep vein thrombosis. Current and future questions]J N Fiessinger
Nouvelle Revue Francaise D'Hematologie|April 1, 1994
Thrombotic complications of polycythemia. The venous and arterial risk factorsJ N Fiessinger
Presse Medicale (Paris, France : 1983)|May 8, 2000
[What are the safety measures for use of low-molecular-weight heparins in the treatment of deep venus thrombosis?]J N Fiessinger
Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
Bulletin De L'Academie Nationale De Medecine|May 1, 1997
[Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook]J N Fiessinger
Annales De Cardiologie Et D'Angeiologie|March 1, 1981
[Spasm and Raynaud's phenomenon]J N Fiessinger
Annals of Vascular Surgery|December 1, 1987
Thrombolytic therapy for venous thrombosisJ N Fiessinger
La Tunisie Medicale|May 3, 2001
[Diagnosis and treatment of deep venous thromboses: towards ambulatory management]J N Fiessinger
Revue Du Rhumatisme (English Ed.)|May 1, 1997
Thromboangiitis obliterans (Buerger's disease)J N Fiessinger
Drugs|December 9, 1998
[Diagnostic and therapeutic stragegies in peripheral obliterative arteriopathy: non-drug treatment]J N Fiessinger
La Revue De Medecine Interne|January 1, 1997
[Preventing and treating venous thrombosis in 1997]J N Fiessinger
Bulletin De L'Academie Nationale De Medecine|April 27, 2002
[Treatment of deep vein thrombosis. Current and future questions]J N Fiessinger
Nouvelle Revue Francaise D'Hematologie|April 1, 1994
Thrombotic complications of polycythemia. The venous and arterial risk factorsJ N Fiessinger
Presse Medicale (Paris, France : 1983)|May 8, 2000
[What are the safety measures for use of low-molecular-weight heparins in the treatment of deep venus thrombosis?]J N Fiessinger
Pageof 31